ZDHHC3 and ovarian cancer: Importantly, genetic inhibition of ZDHHCs (ZDHHC3, 5, 17, 9, 12) has revealed significant therapeutic efficacy in some animal tumor models, including colon cancer, glioblastoma, leukemia, and ovarian cancer.